by Thomas S. Uldrick, and Richard F. Little

Slides:



Advertisements
Similar presentations
Fig FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.
Advertisements

PET Criteria for Response Assessment After Completion of Therapy for Aggressive NHL and HL Definition of a positive PET scan (Visual assessment is adequate,
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy.
Thomas J. Donnelly, MD, Rubin M. Tuder, MD, Thomas R. Vendegna, MD 
Pulmonary Hypertension and Human Immunodeficiency Virus Infection
Hugo J.A. Adams, Rutger A.J. Nievelstein, Thomas C. Kwee  Blood Reviews 
Fig. 10. MIP (A, C) and axial non contrast fused 18F-FDG PET/CT (B) in 20-year-old man with ALK positive anaplastic large cell lymphoma. A. Patient had.
Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.
Staging of diffuse large B-cell lymphoma (DLBCL)
Biological aspects of Epstein–Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies  Hirokazu Kanegane, Keiko.
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
How I treat extramedullary myeloma
Fig. 3.Findings of the 39-year-old man with extrapulmonary mass-like lesions (case 3). (A, B) Abdominal CT on admission day shows multiple hepatic nodules.
by Rahul Matnani, and Karthik A. Ganapathi
by Michele Paessler, and John Choi
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD by Kathrin Rieger, Christoph Loddenkemper, Jochem Maul, Thomas Fietz,
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells by Lucie Heinzerling,
Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose by Wolfgang Römer, Axel-R. Hanauske, Sibylle.
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection by Koen Van Besien, Sonali Smith,
How I treat extramedullary acute myeloid leukemia
Immunoglobulin G4-related multiple cardiovascular lesions successfully treated with a combination of open surgery and corticosteroid therapy  Meikun Kan-o,
Resolution of osteosclerosis after alloHCT in systemic mastocytosis
Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma.
Histopathologic features (all images at ×10 magnification).
Figure Vertebral artery angiogram and tissue pathology
Quiz Page February 2016 American Journal of Kidney Diseases
Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly.
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,
Alicia K. Morgans, MD, Ran Reshef, MD, Donald E. Tsai, MD, PhD 
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients by Arthur E. Frankel,
Caught in transformation
Treatment of 7 patients with relapsed/refractory NK/T-cell lymphomas treated with pembrolizumab. Treatment of 7 patients with relapsed/refractory NK/T-cell.
Figure 1 Muscle biopsy images demonstrating a pauci-immune necrotizing autoimmune myopathy in illustrative cases 1 and 2 (A–D) Case 1 deltoid muscle. Muscle.
Recurrent Brachial Neuritis Attacks in Presentation of B-Cell Lymphoma
Evidence of a Graft-versus-Hodgkin Lymphoma Effect in the Setting of Extensive Bone Marrow Involvement  Paolo Anderlini, MD  Biology of Blood and Marrow.
Extrafacial lupus miliaris disseminatus
Volume 2, Issue 5, Pages (September 2016)
Қош келдіңіздер.
Radiological and pathological findings in a common variable immunodeficiency patient with granulomatous-lymphocytic interstitial lung disease. a) High-resolution.
MR-PET of the body: Early experience and insights
Volume 1, Issue 2, Pages (March 2015)
Clinicopathologic Analysis of POEMS Syndrome and Related Diseases
Volume 148, Issue 5, Pages e142-e147 (November 2015)
Yasuo Miura, MD, PhD, Mitsuru Tsudo, MD, PhD  Mayo Clinic Proceedings 
by Geling Li, Emily Waite, and Julie Wolfson
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL by Monika Pilichowska, Stefania Pittaluga,
The clinical spectrum of Erdheim-Chester disease: an observational cohort study by Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H.
Primary Malignant Ependymoma of the Lung
Insidious: Takayasu Arteritis
Lymphoma Associated With Human Immunodeficiency Virus Infection
Beware of Underlying Malignancy: Acquired Ichthyosis
A 53-year-old male patient with temporal lobe epilepsy (case 31).
A 60-year-old man with HPV+ HNSCC (T3N2M0).
Fig. 3. A: The resected lesion comprised monomorphous tumor cells with moderate cellularity (hematoxylin and eosin staining, original magnification ×100).
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase by Yok-Lam Kwong, Thomas S. Y.
PD-L1 and tumor-associated macrophages in de novo DLBCL
Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient  Richard A. Helmers, MD, Thomas J. Byrne,
by Matthew S. Painschab, Kate D
How I treat Burkitt lymphoma in adults
Figure FDG-PET, lymph node biopsy, and brain MRI
Resistance mechanism for ibrutinib in marginal zone lymphoma
Biology and treatment of Richter syndrome
How I treat early-relapsing follicular lymphoma
Bronchial biopsy from patient 5 (a; Haematoxylin-Eosin-Safran stain and ×10 growth). Bronchial biopsy from patient 5 (a; Haematoxylin-Eosin-Safran stain.
Images of a 52-year-old man who developed acute left hemiparesis, ataxia, and agitation (case 1). Images of a 52-year-old man who developed acute left.
by Lapo Alinari, and Kristie A. Blum
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI by Naranie Shanmuganathan, Susan.
A, Recurrent neoplasm in patient 6.
NI-RADS primary site category 2a: superficial mucosal abnormality.
Presentation transcript:

by Thomas S. Uldrick, and Richard F. Little How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus by Thomas S. Uldrick, and Richard F. Little Blood Volume 125(8):1226-1235 February 19, 2015 ©2015 by American Society of Hematology

Histopathology and immunohistochemistry of HIV-cHL. Histopathology and immunohistochemistry of HIV-cHL. (A) Hematoxylin and eosin staining shows cHL, MC subtype. Immunostaining for (B) CD15, (C) CD30, and (D) EBV latent membrane protein 1 demonstrates Hodgkin Reed-Sternberg cells. (E) CD68 staining showing many (>5%)46 macrophages. (F) Hematoxylin and eosin staining at time of relapse shows cHL, MC subtype. Original magnification ×40. Thomas S. Uldrick, and Richard F. Little Blood 2015;125:1226-1235 ©2015 by American Society of Hematology

18FDG-PET in HIV-cHL. 18FDG-PET in HIV-cHL. (A) Baseline 18FDG-PET. Volumetric image shows bulky intensely hypermetabolic cervical, mediastinal, and axillary lymph nodes and multiple focal bone lesions (representative vertebral lesion, red arrow). (B) Interim 18FDG-PET. At the end of cycle 2, coronal image focuses on a small suspicious lesion in left axilla (red arrow); diffuse bone uptake attributable to pegfilgrastim is also noted. After cycle 6, a biopsy sample of residual abnormalities in the left axilla showed reactive changes and no evidence of cHL. (C) End-of-therapy 18FDG-PET. Volumetric image shows resolution of 18FDG avid nodes. (D) Relapse 18FDG-PET. Volumetric image shows left axillary avid lymph node (red arrow) and other small nodes above the diaphragm. Thomas S. Uldrick, and Richard F. Little Blood 2015;125:1226-1235 ©2015 by American Society of Hematology